CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Alzheimer's disease (AD) is the most common form of dementia. In the brains of people with AD, certain small substances stick toget ...
Phase 2
Warsaw, Poland and 38 other locations
The purpose of this study is to assess the safety, tolerability and effect of study drug LY3372689 in participants with early symptomatic Alzheimer's...
Phase 2
Warszawa, Mazowieckie, Poland and 69 other locations
versus (vs) placebo on the Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) up to Week 80 in study participants with prodromal or mild Alzheimer's...
Phase 2
Warszawa, Poland and 102 other locations
capsules (KarX-EC) in participants with agitation associated with Alzheimer's Disease who completed the parent studies CN012-0023 o...
Phase 3
Sochaczew, Poland and 162 other locations
This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to e...
Phase 3
Warszawa, Poland and 103 other locations
This clinical trial is recruiting people who either are at risk of AD - have build-up of beta-amyloid, but have no clinical symptoms, or with a diagn...
Phase 2
Warszawa, Poland and 55 other locations
In this study, researchers will learn more about a study drug called BIIB080. The study will focus on participants with mild cognitive impairment or...
Phase 2
Warszawa, Poland and 137 other locations
The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease...
Phase 3
Warszawa, Mazowieckie, Poland and 275 other locations
The reason for this study is to assess the safety and efficacy of donanemab in participants with early Alzheimer's disease. The stu...
Phase 3
Warszawa, Mazowieckie, Poland and 142 other locations
The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's...
Phase 3
Sochaczew, Poland and 189 other locations
Clinical trials
Research sites
Resources
Legal